Skip to main content
. 2012 Oct 18;28(1):138–151. doi: 10.1093/humrep/des372

Table III.

Summary statistics (means and SDs) for all measurements at all time points; total stress (PSS), total positive and negative affect (PANAS), physical and mental attributes (SF-12) and cortisol: creatinine and E3G:creatinine ratios.

Total stress Test
Control
Difference test-control 95% CI
n Mean SD n Mean SD
T1—Baseline 114 14.99 4.58 93 14.80 5.10 0.19 −1.15 to 1.54
T2—Cycle 1, Day 6 81 16.11 4.92 63 16.73 6.04 −0.62 −2.47 to 1.24
T3—Cycle 1, Surge Day 73 16.79 4.86 61 16.26 6.08 0.53 −1.38 to 2.44
T4—Cycle 2, Day 6 52 17.29 6.00 51 16.10 5.49 1.19 −1.06 to 3.44
T5—Cycle 2, Surge Day 48 17.25 5.43 47 15.23 5.38 2.02 −0.19 to 4.22
T6—Cycle 3 37 17.76 6.48 40 15.78 6.25 1.98 −0.91 to 4.87
Negative affect
 T1—Baseline 113 14.16 4.03 93 14.37 4.58 −0.21 −1.41 to 0.99
 T2—Cycle 1, Day 6 82 16.29 5.76 62 16.84 6.64 −0.55 1.06 to −2.64
 T3—Cycle 1, Surge Day 73 15.85 5.02 62 15.39 5.02 0.46 0.87 to −1.25
 T4—Cycle 2, Day 6 51 18.37 6.17 50 17.44 6.16 0.93 1.23 to −1.50
 T5—Cycle 2, Surge Day 47 16.62 6.21 47 16.28 6.60 0.34 1.32 to −2.28
 T6—Cycle 3 38 17.55 6.97 40 16.90 6.64 0.65 1.54 to −2.42
Positive affect
 T1—Baseline 114 36.14 7.00 92 37.96 6.26 −1.82 −3.64 to 0.01
 T2—Cycle 1, Day 6 82 32.52 7.06 62 32.16 8.72 0.36 −2.32 to 3.05
 T3—Cycle 1, Surge Day 72 32.58 8.06 62 34.63 7.55 −2.05 −4.72 to 0.62
 T4—Cycle 2, Day 6 50 31.16 8.71 50 33.04 8.16 −1.88 −5.22 to 1.47
 T5—Cycle 2, Surge Day 47 31.55 8.50 47 34.28 7.78 −2.73 −6.06 to 0.61
 T6—Cycle 3 36 29.75 10.24 38 34.26 8.06 −4.51 −8.80 to −0.22
SF-12
 Physical T1—Baseline 115 39.80 3.53 93 39.65 3.28 0.15 −0.78 to 1.10
 Physical T6—Cycle 3, Day 6 38 41.86 4.00 40 41.12 3.14 0.74 −0.87 to 2.37
 Mental T1—Baseline 115 49.57 3.89 93 48.42 4.50 1.15 0.01 to 2.31
 Mental T6—Cycle 3, Day 6 38 46.40 7.15 40 46.15 5.11 0.25 −2.54 to 3.04
Cortisol (µg/dl):Creatinine (g/dl)
 T2—Cycle 1, Day 6 84 136.29 62.82 66 157.23 138.92 −20.94 −57.35 to 15.46
 T3—Cycle 1, Surge Day 69 129.15 70.36 61 149.04 85.20 −19.89 −47.22 to 7.44
 T4—Cycle 2, Day 6 51 147.68 110.30 44 147.57 89.59 0.11 −40.63 to 40.85
 T5—Cycle 2, Surge Day 47 127.75 65.42 45 149.16 92.40 −21.41 −54.70 to 11.88
 T6—Cycle 3 37 139.33 59.03 38 156.23 89.44 −16.9 −51.69 to 17.89
E3G (ng/ml):Creatinine (g/dl)
 T2—Cycle 1, Day 6 84 98.99 56.69 66 101.34 46.23 −2.35 −18.94 to 14.26
 T3—Cycle 1, Surge Day 69 403.15 237.43 61 276.31 180.57 126.84 54.10 to 199.58
 T4—Cycle 2, Day 6 51 104.90 79.52 44 108.32 56.13 −3.42 −31.19 to 24.35
 T5—Cycle 2, Surge Day 47 311.11 206.71 45 261.54 182.65 49.57 −31.14 to 130.28
 T6—Cycle 3 37 101.59 52.34 38 95.24 52.43 6.35 −17.76 to 30.46

The number of evaluable data points may not match those in Fig. 1 because of missing or incomplete questionnaires at specific time points.

(E3G, estrone-3-glucuronide).